Indications

• Xyclin has a high degree of activity against many common respiratory pathogens including S. pneumonia, H. influenzae, M. catarrhalis and anaerobes such as B. fragilis - making it an effective and affordable antibiotic for URTI
  
  
• Inexpensive, broad spectrum antibacterial coverage
  
  
• A valuable antibiotic for many infectious diseases especially where economy is an important consideration
  
  
• Potentially a valuable treatment against penicillin resistant S. pneumoniae.
  
  
• Minimal resistance potential, unlike some of the newer generation of antibiotics